XLO icon

Xilio Therapeutics

33 hedge funds and large institutions have $52.2M invested in Xilio Therapeutics in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less funds holding

Funds holding:

less funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

58% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 12

61% less capital invested

Capital invested by funds: $133M → $52.2M (-$80.5M)

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$502K
2 +$417K
3 +$220K
4
Millennium Management
Millennium Management
New York
+$146K
5
B
Bailard
California
+$107K

Top Sellers

1 -$1.15M
2 -$1.03M
3 -$812K
4
BlackRock
BlackRock
New York
-$735K
5
State Street
State Street
Massachusetts
-$229K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.19M
2
$8.06M
3
$7.36M
4
$6.07M
5
$4.82M
6
$4.21M
7
$3.98M
8
$1.95M
9
$1.32M
10
$1.31M
11
$1.22M
12
$1.22M
13
$639K
14
$417K
15
$356K
16
$244K
17
$220K
18
$146K
19
$139K
20
$107K
21
$51K
22
$46K
23
$38K
24
$29K
25
$20K